3rd Quarter - Report
GEPHARDT GROUP GOVERNMENT AFFAIRS for TEVA PHARMACEUTICALS USA, INC.
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S.1720, Patent Transparency and Improvements Act of 2013
Foreign entity interest: Teva Pharmaceuticals Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANICE O'CONNELL | — |
Health Issues HCR
opiate abuse
Foreign entity interest: Teva Pharmaceuticals Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANICE O'CONNELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.